For immediate release
Contact: Gary Sender
Chief Financial Officer
Tengion, Inc.
gary.sender@tengion.com
Tengion's Autologous Organ Regeneration Platform™, with a focus on the development of the company's first investigational product, the Tengion Neo-Bladder™, was featured on the CBS Evening News on Wednesday, February 6, 2008. Tengion's President and CEO, Dr. Steven Nichtberger was interviewed for the story. This news coverage was part of a two-night series titled "Growing Miracles" reported by CBS News National Correspondent Wyatt Andrews, and it explored the current landscape and future potential of regenerative medicine.
About Tengion
Tengion, a clinical stage biotechnology company, has pioneered the Autologous Organ Regeneration Platform™ that catalyzes the body's innate ability to regenerate. Tengion's neo-organs and neo-tissues in development, such as bladders and vessels, combine biocompatible materials and a patient's own (autologous) cells to regenerate diseased and failing organs and tissues. Tengion's product candidates have the potential to cure - rather than treat - organ and tissue failure, enabling people to lead healthier lives without donor transplants or the side effects of related therapies. For more information on the company and current clinical trials, visit Tengion online at: http://www.tengion.com.